McCormack, M. P., Forster, A., Drynan, L., Pannell, R., & Rabbitts, T. H. (2003). The LMO2 T-Cell Oncogene Is Activated via Chromosomal Translocations or Retroviral Insertion during Gene Therapy but Has No Mandatory Role in Normal T-Cell Development. American Society for Microbiology.

McCormack, Matthew P., Alan Forster, Lesley Drynan, Richard Pannell, et Terence H. Rabbitts. The LMO2 T-Cell Oncogene Is Activated Via Chromosomal Translocations or Retroviral Insertion During Gene Therapy but Has No Mandatory Role in Normal T-Cell Development. American Society for Microbiology, 2003.

McCormack, Matthew P., et al. The LMO2 T-Cell Oncogene Is Activated Via Chromosomal Translocations or Retroviral Insertion During Gene Therapy but Has No Mandatory Role in Normal T-Cell Development. American Society for Microbiology, 2003.